Cohort study on ischemic stroke patients
Official title: a Prospective, Multicenter Cohort Study of Ischemic Cerebrovascular Disease
Run by Xiangya Hospital of Central South University · NCT05922540 · Data updated 2026-11-12
This study is trying to gather information from a large group of people who have had an ischemic stroke to see if certain biological markers can help predict risks and outcomes for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Xiangya Hospital of Central South University Academic / other |
| Locations | 1 site (Hunan) |
| Status | Recruiting |
| Started | November 1, 2022 |
| Main results expected | November 1, 2026 |
| Study ends | November 1, 2027 |
| Registry record updated | June 28, 2023 |
| Trial ID | NCT05922540 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have been clinically diagnosed with ischemic stroke.
✕Probably not a fit
Patients with moderate to severe mental disorders, concurrent malignant tumors, or those unable to cooperate with study procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to create a large-scale, multicenter cohort of patients diagnosed with ischemic stroke. It involves the collection of various biological samples, including blood, feces, and urine, to identify potential biomarkers linked to ischemic stroke. The study will integrate demographic data, clinical indicators, imaging parameters, and biomarker information to develop models for risk assessment, early warning, and prognosis prediction. Additionally, it seeks to identify key genes and explore relevant signaling pathways associated with ischemic stroke.
Why it matters
Potential benefit: If successful, this study could lead to improved risk assessment and treatment strategies for patients suffering from ischemic stroke.
How similar studies have gone: Other studies have shown promise in identifying biomarkers for ischemic stroke, suggesting that this approach could yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Clinical diagnosis of ischemic stroke. 2. Age ≥ 18 years. 3. Signed informed consent form. Exclusion Criteria: 1. Patients with moderate to severe mental disorders or dementia who cannot cooperate to complete the informed consent and follow-up procedures. 2. Patients with neurological functional impairment caused by conditions such as migraine aura, epilepsy, or other non-ischemic strokes. 3. Agitated patients who cannot cooperate with imaging examinations. 4. Pregnant or lactating patients, as well as those planning to become pregnant within 90 days. 5. Patients with concurrent malignant tumors or severe systemic diseases with an expected survival period of less than 90 days. 6. Patients who have participated in other clinical studies within 30 days prior to enrollment or are currently participating in other interventional clinical studies.
Where it's running
-
Xiangya Hospital, Central South University
Hunan, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Minocycline added to standard IV thrombolysis in acute ischemic stroke
This trial tests whether giving minocycline around the time of IV thrombolysis improves functional recovery after an acute ischemic stroke.
-
Exploring the effects of BCI-FES hand therapy on swallowing and speech in stroke patients
This study is testing whether a new therapy using brain signals and electrical stimulation can help stroke patients improve their swallowing and speech abilities.
-
Belzutifan as a preoperative option for pheochromocytoma/paraganglioma
This study tests whether belzutifan can safely help prepare patients with pheochromocytoma or paraganglioma for surgery and reduce catecholamine-related effects.
-
Chinese multicenter group studies spontaneous intracerebral hemorrhage in adults
This study tests how a large group of adults with spontaneous intracerebral hemorrhage (and a healthy control group) progress over time to understand outcomes and determinants of recovery.
-
How anxiety and depression relate to asthma control and the risk of flare-ups
This observational study tests whether anxiety and depression affect how well asthma controller medicines work and whether a risk model can predict asthma flare-ups.
-
Midline glioma MRI AI model: preoperative molecular subtyping and prognosis
This study tests an MRI-based AI model to predict key molecular subtypes and prognosis for patients with midline gliomas before surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.